Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention
Read More Pharma Industry News Is a C$16m LIFE offering from ZYUS Life Sciences the catalyst investors are watching in cannabinoid pharma? ZYUS Life Sciences launches a C$15–16 million LIFE offering to accelerate clinical execution and regulatory readiness. Find out what it means for investors. bySoujanya RaviJanuary 15, 2026